Barinthus Biotherapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Barinthus Biotherapeutics's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 98% to $802,000. The net income dropped to -$73,347,000 and profit margin reached -9146%. Total operating expenses were $84,716,000.
Profit Margin
| 2019 | 6.87M | -20.81M | -302.84% |
|---|---|---|---|
| 2020 | 4.82M | -17.70M | -367.27% |
| 2021 | 268K | -50.86M | -18979.48% |
| 2022 | 44.70M | 5.34M | 11.95% |
| 2023 | 802K | -73.34M | -9145.51% |
BRNS Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 802K | 44.70M | 268K | 4.82M | 6.87M |
Cost of revenue | 0 | 0 | 0 | 0 | 0 |
Gross profit | 802K | 44.70M | 268K | 4.82M | 6.87M |
Operating exp. | |||||
Research and development | 44.87M | 41.11M | 16.37M | 11.10M | 29.96M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 84.71M | 47.50M | 41.48M | 21.58M | 32.29M |
Operating income | -83.91M | -4.04M | -45.22M | -20.04M | -25.77M |
Other income (expenses), net | 7.39M | 567K | -7.25M | 2.20M | 2.97M |
Income before tax | -76.52M | 850K | -51.14M | -17.83M | -22.79M |
Income tax expense | -3.17M | -4.47M | -28K | 95K | -2.01M |
Net income | -73.34M | 5.34M | -50.86M | -17.70M | -20.81M |
Earnings per share | |||||
Basic EPS | -1.91 | 0.14 | -1.37 | -371.62 | 0 |
Diluted EPS | -1.91 | 0.14 | -1.37 | -371.62 | 0 |
| Data source |